FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
FDA General

Since Our Last Issue ...

Industry news you may have missed since our last issue.

FDA General

Product Approval Summaries

FDA Review posts product approval for the week ending 9/24/2021.

Medical Devices

Armstrong Medical Recalls Anesthesia Gas Cans

Armstrong Medical recalls its Amsorb Plus Prefilled G-Can 1.0L due to reports that some canisters have difficulties with gas flow that may cause a red...

Federal Register

Sunscreen OTC Monograph Proposed Order Available

Federal Register notice: FDA makes availability of an over-the-counter monograph proposed order entitled Amending Over-the-Counter (OTC) Monograph M02...

Federal Register

FDA Revokes 3 EUAs for No-longer-marketed Tests

Federal Register notice: FDA revokes the emergency use authorizations for three Covid-19 tests after the companies requested such because the tests ar...

Human Drugs

FDA Generic Drugs Office Modifies Scientific Priorities

The CDER Office of Generic Drugs revises its scientific priorities as part of its user fee performance goals through 2022.

Biologics

FDA Approves Expanded Repatha Use

FDA approves an Amgen supplemental BLA for Repatha (evolocumab) injection as an add-on treatment to diet alone or together with certain other therapie...

Human Drugs

FDA Approves Tivdak for Cervical Cancer

FDA grants Genmab and Seagen accelerated approval for their BLA for Tivdak (tisotumab vedotin-tftv), an antibody-drug conjugate for treating certain a...

Human Drugs

FDA Extends Review of Pfizer Growth Hormone

FDA extends by three months the review of a Pfizer/Opko Health BLA for somatrogon, a once-weekly long-acting recombinant human growth hormone for trea...

Federal Register

Advisory Panel to Discuss Reata Pharma NDA

Federal Register notice: FDA announces a 12/8 Cardiovascular and Renal Drugs Advisory Committee meeting to discuss a Reata Pharmaceuticals NDA for its...